170 related articles for article (PubMed ID: 38562854)
1. Cannabinoid Receptor Signaling is Dependent on Sub-Cellular Location.
Thomas A; Lobingier BT; Schultz C; Laguerre A
bioRxiv; 2024 Mar; ():. PubMed ID: 38562854
[TBL] [Abstract][Full Text] [Related]
2. Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors.
Scott-Dennis M; Rafani FA; Yi Y; Perera T; Harwood CR; Guba W; Rufer AC; Grether U; Veprintsev DB; Sykes DA
Front Pharmacol; 2023; 14():1158091. PubMed ID: 37637423
[No Abstract] [Full Text] [Related]
3. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
[TBL] [Abstract][Full Text] [Related]
4. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB
Horváth VB; Soltész-Katona E; Wisniewski É; Rajki A; Halász E; Enyedi B; Hunyady L; Tóth AD; Szanda G
Front Endocrinol (Lausanne); 2021; 12():740913. PubMed ID: 34745007
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of adenosine A1 and cannabinoid 1 receptor signaling by G-peptides.
Touma AM; Malik RU; Gupte T; Sivaramakrishnan S
Pharmacol Res Perspect; 2020 Dec; 8(6):e00673. PubMed ID: 33124765
[TBL] [Abstract][Full Text] [Related]
7. Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease.
Bagher AM; Laprairie RB; Kelly MEM; Denovan-Wright EM
Methods Mol Biol; 2018; 1780():549-571. PubMed ID: 29856035
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB
Kline T; Xu C; Kreitzer FR; Hurst DP; Eldeeb KM; Wager-Miller J; Olivas K; Hepburn SA; Huffman JW; Mackie K; Howlett AC; Reggio P; Stella N
Eur J Med Chem; 2023 Mar; 249():115123. PubMed ID: 36708677
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Ward RJ; Pediani JD; Milligan G
Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
12. The Leu/Val
Llinas Del Torrent C; Raïch I; Gonzalez A; Casajuana-Martin N; Lillo J; Rebassa JB; Ferreiro-Vera C; Sánchez de Medina V; Franco R; Navarro G; Pardo L
J Chem Inf Model; 2023 Sep; 63(18):5927-5935. PubMed ID: 37644761
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor interacting protein suppresses agonist-driven CB
Blume LC; Leone-Kabler S; Luessen DJ; Marrs GS; Lyons E; Bass CE; Chen R; Selley DE; Howlett AC
J Neurochem; 2016 Nov; 139(3):396-407. PubMed ID: 27513693
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.
Shim JY; Ahn KH; Kendall DA
J Biol Chem; 2013 Nov; 288(45):32449-32465. PubMed ID: 24092756
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling.
Chiang YC; Lo YN; Chen JC
J Neurochem; 2013 Oct; 127(2):163-76. PubMed ID: 23952963
[TBL] [Abstract][Full Text] [Related]
16. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
Prather PL; FrancisDevaraj F; Dates CR; Greer AK; Bratton SM; Ford BM; Franks LN; Radominska-Pandya A
Biochem Biophys Res Commun; 2013 Nov; 441(2):339-43. PubMed ID: 24148245
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.
Ibsen MS; Finlay DB; Patel M; Javitch JA; Glass M; Grimsey NL
Front Pharmacol; 2019; 10():350. PubMed ID: 31024316
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
[TBL] [Abstract][Full Text] [Related]
20. Cannabigerol Action at Cannabinoid CB
Navarro G; Varani K; Reyes-Resina I; Sánchez de Medina V; Rivas-Santisteban R; Sánchez-Carnerero Callado C; Vincenzi F; Casano S; Ferreiro-Vera C; Canela EI; Borea PA; Nadal X; Franco R
Front Pharmacol; 2018; 9():632. PubMed ID: 29977202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
